In comparison to these studies, our findings suggest that CpG-ODNs may alleviate renal injury caused by cervical cancer radiotherapy (RKI) by inhibiting the activation of the PARP1/XRCC1 signaling axis, thus suppressing DNA damage and oxidative stress responses in renal tubular epithelial cells. The gene discussed is PARP1; the disease is cervical carcinoma.